30, 60, and 90-Day Inpatient Opiate Rehab Programs Compared

The "60% rule" in rehab is a Medicare reimbursement requirement — not a measure of treatment success. It means inpatient rehabilitation facilities must show that at least 60% of patients have qualifying conditions for billing purposes. For opioid treatment, program length should be guided by ASAM criteria, not this metric.

30, 60, and 90-Day Opiate Rehab: Which Length Is Right?

Inpatient opioid treatment comes in three standard program lengths. Each was developed for specific clinical contexts, and each has a legitimate place in the care continuum. The question is not "which length is best" but "which length is appropriate for this patient based on severity, prior treatment history, and the home environment they are returning to."

Length	Best for	Typical ASAM level	Continuing care
30 days	First-time treatment, lower severity, stable home environment, strong step-down plan	3.5 after detox at 3.7	PHP or IOP for 8–12 weeks, MAT continuation
60 days	Moderate severity, prior relapse, some instability in recovery environment	3.5 with extended stay	IOP for 12 weeks, ongoing MAT, sober living
90 days	Severe dependence, multiple prior treatment episodes, co-occurring conditions, unstable home	3.5 or 3.7 across stay	Extended IOP/PHP, long-term MAT, sober living or transitional housing

What the Research Says About Program Length for Opioid Addiction

A consistent finding across decades of addiction-medicine research is that longer treatment correlates with better one-year outcomes for opioid use disorder. The relationship is not linear and has diminishing returns, but the direction is clear: 90 days outperforms 60 days on most measures, and 60 days outperforms 30 days. The effect size varies by substance and by methodology, but the consensus is strong enough that NIDA has built its public guidance around it.

Why 30 days is often insufficient for opioid dependence

Opioid withdrawal acute phase typically resolves in 5 to 10 days for short-acting opioids and 14 to 21 days for long-acting opioids like methadone. After acute detox, the brain is still in post-acute withdrawal: anhedonia, mood instability, sleep disruption, and intense craving persist for weeks to months. A 30-day program covers detox plus about three weeks of post-acute stabilization — enough to establish medication-assisted treatment and begin behavioral therapy, but typically not enough to consolidate recovery skills, address underlying trauma or co-occurring conditions, or build the confidence to return to a high-risk environment.

This is why 30-day programs work best when paired with a structured step-down — 8 to 12 weeks of intensive outpatient or partial hospitalization after discharge, with MAT continuation. A 30-day admission followed by no continuing care has one of the weakest outcomes in the literature. The length of stay that matters is not the inpatient number alone but the total structured-care envelope.

NIDA's recommendation: 90 days minimum for best outcomes

The National Institute on Drug Abuse's "Principles of Drug Addiction Treatment" publication identifies 90 days as the threshold below which treatment is of limited effectiveness. The 90-day figure is not arbitrary — it corresponds roughly to the clinical window during which the earliest measurable recovery in brain function occurs and during which most patients consolidate the behavioral skills needed for sustained abstinence. It is not a cap. Continuing care beyond 90 days, particularly MAT continuation for 12 months or longer, is associated with further outcome improvement. For patients with severe dependence, multiple relapses, or co-occurring psychiatric conditions, the 90-day figure is a floor, not a ceiling.

The 60% Rule Explained (and Why It Doesn't Mean What You Think)

"What is the 60% rule in rehab?" is among the most-searched questions on this topic, and almost every top search result gets it at least partly wrong. This section exists specifically to correct the record. The 60% rule is an administrative requirement from the Centers for Medicare & Medicaid Services (CMS), codified in federal regulation at 42 CFR §412.29. It applies to Inpatient Rehabilitation Facilities (IRFs) that want to receive Medicare reimbursement at IRF rates rather than the lower rate applied to skilled nursing facilities.

The rule works as follows. An IRF must demonstrate that at least 60% of its Medicare patient population has a primary diagnosis from a specific list of 13 CMS-approved qualifying conditions (stroke, spinal cord injury, amputation, brain injury, certain neurological conditions, etc.). If the facility meets the 60% threshold, it is reimbursed as an IRF. If not, it is reimbursed at the lower long-term-care rate. That is the entire substance of the rule.

What the rule does not mean: it is not a success rate, not a completion rate, not a sobriety rate, not a clinical effectiveness benchmark, and not an insurance payment gate for commercial plans. It does not apply to substance use treatment facilities, which are not classified as IRFs. Patients searching for "60% rule rehab" are almost always trying to understand treatment effectiveness and are reading a Medicare billing specification that has nothing to say on that question.

For opioid treatment decisions specifically, the relevant framework is the ASAM criteria, not the 60% rule. ASAM determines the appropriate level of care; the treatment team re-evaluates medical necessity at 7- to 14-day intervals; and length of stay is a clinical decision, not a billing metric.

30-Day Programs: Who They Work For

A 30-day inpatient program is the most common entry point and is appropriate for patients with mild-to-moderate severity, a stable recovery environment at home, supportive family or housing, and a documented step-down plan to intensive outpatient care. It is also appropriate as a medically necessary detox-and-initial-stabilization stay for patients who will transition directly into PHP or IOP as the primary treatment phase. The 30-day length is also most often the length that commercial insurance plans initially authorize, with extensions granted on documented continued medical necessity. When 30 days is the right length, it is because the structured continuing-care plan picks up where inpatient leaves off.

60-Day Programs: The Middle Ground

A 60-day program is appropriate for patients with moderate-to-severe dependence, at least one prior relapse, some instability in the home environment, or co-occurring conditions that require additional stabilization time. The second 30 days are typically used for deeper behavioral work, trauma-focused therapy when indicated, family programming, and reintegration planning. Patients in 60-day programs usually solidify MAT dosing, develop a written relapse prevention plan, and begin measured reintegration activities (supervised outings, family meetings, vocational assessment) in the final weeks. Insurance coverage of 60-day stays is routine under parity rules when continued medical necessity is documented.

90-Day Programs: When Extended Stay Matters

A 90-day program is appropriate for severe opioid use disorder, multiple prior treatment episodes, unstable housing or recovery environment, significant co-occurring psychiatric conditions, or patients where the clinical team identifies continued high relapse risk at 30 and 60 days. The final 30 days are oriented around transitional living, longer supervised outings, structured reintegration, and coordination with a post-discharge treatment team. NIDA's minimum 90-day recommendation aligns with the neurobiology of post-acute withdrawal and with the behavioral-skills timeline. Length can be extended further when the ASAM reassessment supports it.

What Happens After Inpatient: Continuing Care Planning

Treatment does not end at residential discharge. The evidence-based continuing care package includes four elements:

• Step-down clinical care. Partial hospitalization (5 days/week, 6 hours/day) or intensive outpatient (3 days/week, 3 hours/day) for 8–16 weeks after residential discharge.
• MAT continuation. Buprenorphine, naltrexone, or methadone continuation coordinated at discharge with an office-based prescriber or specialized program. Most patients benefit from at least 12 months of MAT continuation; many benefit longer.
• Recovery support. Peer recovery groups (12-step, SMART Recovery, program alumni networks), sober living or transitional housing when home environment is unstable, and vocational support.
• Ongoing clinical monitoring. Regular check-ins with a primary-care or addiction-medicine physician, periodic toxicology, and mental health follow-up for co-occurring conditions.

The total structured-care envelope — inpatient plus continuing care — is the outcome-relevant measure, not the inpatient length alone. A 30-day inpatient plus 12 weeks of structured IOP and 12 months of MAT can produce outcomes comparable to a 90-day inpatient followed by minimal continuing care.

Frequently Asked Questions

What is the 60% rule in rehab?

The 60% rule is a Medicare reimbursement requirement — not a measure of treatment success. It requires inpatient rehabilitation facilities (IRFs) seeking Medicare payment to demonstrate that at least 60% of their patients have qualifying diagnoses from a specific CMS list. The rule is administrative — about which facilities qualify for higher Medicare reimbursement — and has nothing to do with success rates, completion percentages, or the clinical effectiveness of any specific length of stay. For opioid treatment, program length should be guided by ASAM criteria and clinical progress, not by this billing metric.

Is 30 days in rehab enough for opioids?

For many opioid patients, 30 days is a reasonable starting point but not the optimal endpoint. NIDA's publicly stated guidance is that treatment lasting less than 90 days is of limited effectiveness, and research has consistently found that longer residential stays correlate with better one-year outcomes for moderate-to-severe opioid use disorder. Many patients who start with a 30-day admission extend into a 60- or 90-day length when the treatment team documents continued medical necessity. A 30-day stay is frequently appropriate when followed by intensive outpatient step-down care.

What does NIDA say about program length for opioid addiction?

NIDA's "Principles of Drug Addiction Treatment" identifies 90 days as the minimum clinical length associated with reliably better outcomes. The principle is that opioid use disorder is a chronic condition requiring sustained engagement — acute medical detox in 5–10 days does not by itself produce lasting recovery. The 90-day recommendation is not a cap; continued care beyond 90 days in step-down forms (outpatient MAT, recovery support) is associated with further improvement in outcomes.

Will insurance cover 90 days of inpatient rehab?

Often yes, when the facility documents continued medical necessity. Most commercial plans do not impose a hard day cap; they authorize care in 7- to 14-day increments and re-authorize each increment based on ASAM criteria and clinical progress. The parity rules under MHPAEA prohibit insurers from applying stricter day limits to substance use treatment than to medical-surgical care. Long stays require ongoing documentation by the admitting clinician, which the facility's utilization-review team handles.

What happens after inpatient treatment ends?

Continuing care begins as soon as residential discharge. The most common step-down levels are partial hospitalization (PHP — 5 days/week, 6 hours/day), intensive outpatient (IOP — 3 days/week, 3 hours/day), and standard outpatient (weekly therapy plus MAT medication management). Sober living housing, recovery support meetings (AA, NA, SMART Recovery, or program alumni networks), and employer reintegration plans round out the continuing-care package. MAT continuation is central — many patients stay on buprenorphine or naltrexone for 12 months or longer.